Intracellular Th Stock Filter Stocks by Fundamentals
ITCI Stock | USD 74.01 0.53 0.71% |
Intracellular Th fundamentals help investors to digest information that contributes to Intracellular's financial success or failures. It also enables traders to predict the movement of Intracellular Stock. The fundamental analysis module provides a way to measure Intracellular's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intracellular stock.
Intracellular | Cash Flow from Operations |
Intracellular Current Valuation Drivers
We derive many important indicators used in calculating different scores of Intracellular from analyzing Intracellular's financial statements. These drivers represent accounts that assess Intracellular's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Intracellular's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 623.1M | 1.9B | 4.3B | 5.0B | 6.9B | 7.2B | |
Enterprise Value | 568.2M | 1.8B | 4.2B | 4.8B | 6.7B | 7.1B |
Intracellular Fundamentals
Return On Equity | -0.22 | ||||
Return On Asset | -0.13 | ||||
Profit Margin | (0.30) % | ||||
Operating Margin | (0.26) % | ||||
Current Valuation | 6.74 B | ||||
Shares Outstanding | 97.48 M | ||||
Shares Owned By Insiders | 2.49 % | ||||
Shares Owned By Institutions | 98.60 % | ||||
Number Of Shares Shorted | 3.47 M | ||||
Price To Earning | (6.56) X | ||||
Price To Book | 10.78 X | ||||
Price To Sales | 13.73 X | ||||
Revenue | 462.18 M | ||||
Gross Profit | 95.16 M | ||||
EBITDA | (158.85 M) | ||||
Net Income | (139.67 M) | ||||
Cash And Equivalents | 628.74 M | ||||
Cash Per Share | 6.64 X | ||||
Total Debt | 16.94 M | ||||
Debt To Equity | 0.04 % | ||||
Current Ratio | 9.81 X | ||||
Book Value Per Share | 6.14 X | ||||
Cash Flow From Operations | (124.2 M) | ||||
Short Ratio | 5.29 X | ||||
Earnings Per Share | (1.46) X | ||||
Target Price | 90.04 | ||||
Number Of Employees | 610 | ||||
Beta | 1.01 | ||||
Market Capitalization | 7.27 B | ||||
Total Asset | 728.29 M | ||||
Retained Earnings | (1.62 B) | ||||
Working Capital | 544.25 M | ||||
Current Asset | 541.82 M | ||||
Current Liabilities | 140.69 M | ||||
Net Asset | 728.29 M |
About Intracellular Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intracellular Th's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intracellular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intracellular Th based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Intracellular Piotroski F Score and Intracellular Altman Z Score analysis. Note that the Intracellular Th information on this page should be used as a complementary analysis to other Intracellular's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Intracellular Stock analysis
When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Intracellular's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.46) | Revenue Per Share 4.843 | Quarterly Revenue Growth 0.503 | Return On Assets (0.13) | Return On Equity (0.22) |
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.